[link removed]

Research findings reported over the past month include advances in our understanding of an area of the brain that may contribute to Sudden Unexpected Death in Epilepsy ([link removed]) (SUDEP) in children, as well as intriguing discoveries about autoantibody-induced epilepsy ([link removed]) . In addition, scientists are turning to plants ([link removed]) to identify novel anti-seizure drugs (ASDs) for novel anti-seizure medications. Finally, we spotlight a development for a model of the NeuroPace responsive neurostimulator ([link removed]) (RNS®), which will broaden its availability as a treatment option, and strike a precautionary note about the effectiveness of
multiple epilepsy surgeries ([link removed]) .

Summaries of these research discoveries and news highlights are below.


** Research Discoveries & News
------------------------------------------------------------
* SUDEP in Children: A specific area of the brain called the amygdala may play a role in causing children to stop breathing during a seizure. The findings could have important implications for predicting, treating, and/or preventing SUDEP in children. Learn More ([link removed])
* Immune System and Epilepsy: In some people with epilepsy, an autoantibody (an antibody that attacks a person’s own body instead of a disease-causing agent) appears to “sneak” into neurons in an area of the brain called the hippocampus, leading to inflammation and then seizures. This study also suggests that it may be possible to prevent these types of seizures with immunosuppressant drugs. Learn More ([link removed])
* Novel Anti-Seizure Drugs (ASDs): Extracts made from magnolia bark, a plant used in traditional Chinese medicine as an anti-seizure remedy, reduced seizures in both zebrafish and mouse models of epilepsy, according to a recent study. The researchers state the isolated compound, magnolol, may serve as a starting point for the development of improved treatments for drug-resistant epilepsy. Learn More ([link removed])
* RNS Device: The NeuroPace RNS system, model RNS-320, received FDA approval for use with magnetic resonance imaging (MRI) machines. This approval means that epilepsy patients who require MRI monitoring can now be offered this model of the RNS as a treatment option as appropriate. Learn More ([link removed])
* Neurosurgery: For patients with drug-resistant epilepsy who undergo multiple neurosurgeries, the likelihood of long-term seizure control decreases with each attempt, according to this study. Learn More ([link removed])

------------------------------------------------------------

Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed] [link removed] [link removed] [link removed] [link removed]

View this email in your browser. ([link removed])

Our mailing address is:
Citizens United for Research in Epilepsy (CURE)
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Update your preferences ([link removed]) or unsubscribe from this list ([link removed])
In the past you provided Citizens United for Research in Epilepsy your email address. Occasionally, you will receive updates from CURE about epilepsy research and news.